Long-term follow-up of the BFR14 trial showed that Gleevec (imatinib) remains effective in advanced gastrointestinal stromal ...
Neoadjuvant TKI therapy in non-metastatic GIST patients can reduce surgical complexity, with CE-CT imaging predicting benefits in 22 of 39 patients. Significant tumor volume reduction was observed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback